drugset / Trial / NCT01770431
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
Phase 4
Completed
1044 enrolled
Qidong Gaitianli Medicines Co., Ltd
Huazhong University of Science and Technology · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy and safety of Huaier Granule for prevention of recurrence and metastasis of hepatocarcinoma after radical hepatectomy.
Timeline
- Start
- 2011-08
- Primary completion
- 2016-08
- Completion
- 2016-08
Outcome
Met primary endpoint
registry analysis (superiority test); Huaier Granule Group vs Bank-control Group; p = 0.0001; chi-squared 14.7315; Cochran-Mantel-Haenszel NCT01770431 ↗
paper The difference in the RFS rate between Huaier and control groups was 62.39% and 49.05% (95% CI 6.74 to 19.94; p=0.0001); PMID 29802174 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huaier Granule | Traditional medicine (herbal / TCM) | 20 g | Oral |